Brandon van Buren - 18 Mar 2026 Form 3 Insider Report for Cellebrite DI Ltd. (CLBT)

Reporting relationship: Director
Issuer ticker: CLBT
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 08:06:20 UTC
Prior SEC filing: 15 Jul 2021
Source filing: View source filing
Reporting owner signature: /s/ Brandon Van Buren

Key filing fact

Brandon van Buren filed Form 3 for Cellebrite DI Ltd. (CLBT) on 18 Mar 2026.

Key facts

This page summarizes Brandon van Buren's Form 3 filing for Cellebrite DI Ltd. (CLBT).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 08:06.

Change

Previous filing in this sequence was filed on 15 Jul 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001767764 Primary reporting owner

Van Buren Brandon

Relationship: Director
Address: 94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL
Signature: /s/ Brandon Van Buren
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLBT holding

Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 35,554
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 10,601 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 17, 2025 and vest on September 17, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.